Pr EP injectable

New Study: Injectable PrEP is Safe and Highly Effective

Jul 08, 2020 | Julia Zigman

New data further shows an injectable antiretroviral for HIV pre-exposure prophylaxis (PrEP) is safe and highly effective in reducing HIV risk cisgender men and transgender women who have sex with men.

At the 23rd International AIDS Conference researchers from the HIV Prevention Trials Network (HPTN) released data comparing rates of HIV among trial participants who received the bi-monthly injection, and those who received daily oral tenofovir/emtricitabine (TDF/FTC). While both strategies reduced HIV risk among participants, the injectable strategy was more effective compared to oral PrEP.

The only currently licensed PrEP medications—daily oral pills containing the HIV drugs tenofovir and emtricitabine—are highly effective at preventing HIV when taken as prescribed. However, taking a pill daily can be challenging. A long-acting form of PrEP could offer a less frequent, more discreet option that may be more desirable for some people. HPTN 083 and an ongoing companion study called HPTN 084, which is evaluating long-acting injectable cabotegravir for HIV prevention in cisgender women in sub-Saharan Africa, are sponsored by NIH’s National Institute of Allergy and Infectious Diseases (NIAID).

Read more at HIV.gov and at AVAC.org.


NACCHO logo small version02 square N pms321 Invert

About Julia Zigman

Pronouns: she/her

Julia Zigman is a Program Analyst on the NACCHO HIV, STI, & Viral Hepatitis team. Julia focuses primarily on NACCHO’s Ending the HIV Epidemic portfolio and is a lead staff member for the HIV, STI, and Viral Hepatitis Workgroup. Learn more about these programs here.

More posts by Julia Zigman

Related Posts

1
  • Emergency Response
  • Maternal, Child, & Adolescent Health

Building Community Resilience Through Maternal and Child...

NACCHO, with funding from the Centers for Disease Control and Prevention’s...

Mar 15, 2024 | Elana Filipos

Building Community Resilience Through Maternal and Child...

  • HIV, STI, & Viral Hepatitis

CDC Study Reveals Increase in Overdoses Associated with...

A recent CDC study demonstrates a need for LHDs and other local harm reduction...

Mar 14, 2024 | Kat Kelley, Anjana Rao, Grace Murtha

CDC Study Reveals Increase in Overdoses Associated with...

1
  • Emergency Response
  • Maternal, Child, & Adolescent Health

Bridging Maternal-Child Health (MCH), Infectious Disease...

Funded through the Center for Disease Control and Prevention’s (CDC) National...

Mar 12, 2024 | Elana Filipos

Bridging Maternal-Child Health (MCH), Infectious Disease...

Thumbnail youtube
  • Tools & Resources
  • Adverse Childhood Experiences (ACEs)

NACCHO Releases “Community Partnerships to Prevent...

The National Association of County and City Health Officials is pleased to...

Mar 12, 2024 | Camille Adams

NACCHO Releases “Community Partnerships to Prevent...

1
  • Maternal, Child, & Adolescent Health

NACCHO Provides Funding to Local Health Departments to...

The Maternal, Child, and Adolescent Health team has selected 14 new local...

Mar 11, 2024 | Ryanna Quazi

NACCHO Provides Funding to Local Health Departments to...

NACCHO Cognitive Health Guide FINAL 1
  • Tools & Resources
  • Healthy Aging
  • Healthy Living & Prevention
  • Mobilizing for Action through Planning and Partnerships (MAPP)

New NACCHO Resource: Integrating Brain Health into...

NACCHO, in partnership with the Alzheimer’s Association, is thrilled to launch...

Mar 01, 2024 | Andrea Grenadier

New NACCHO Resource: Integrating Brain Health into...

  • HIV, STI, & Viral Hepatitis
  • HIV, STI, Viral Hepatitis, and Harm Reduction Digest

Digest (February 28, 2024)

HIV, STI, Viral Hepatitis, and Harm Reduction Digest: February 28, 2024

Mar 01, 2024

Digest (February 28, 2024)

EHE Superstars Investing in Community Voices in LA County
  • HIV, STI, & Viral Hepatitis

EHE Superstars: Investing in Community Voices in LA...

This blog continues our new series highlighting collaborative projects between...

Feb 28, 2024 | Anthony Green

EHE Superstars: Investing in Community Voices in LA...

I Stock 1490413668
  • Emergency Response
  • Maternal, Child, & Adolescent Health

Announcing NACCHO’s 2023-2024 Virtual Learning...

NACCHO, with support from the Centers for Disease Control and Prevention’s...

Feb 16, 2024 | Harpur Schwartz, Elana Filipos

Announcing NACCHO’s 2023-2024 Virtual Learning...

Back to Top